Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 05/28/15 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated April 23, 2015 (the "Circular") for the Annual Meeting of Shareholders were elected as directors of the Company at the Annual Meeting of Shareholders held in Durham, North Carolina on May 28, 2015 (the "Meeting"). Detailed results of the vote for the election of directors are set out below:

----------------------------------------------------------------------------

                                                      Votes       % Votes
Name of Nominee           Votes For   % Votes For    Withheld     Withheld
----------------------------------------------------------------------------
Dr. Khalid Islam          5,811,119      99.96%       2,467        0.04%
----------------------------------------------------------------------------
Mr. Adrian Haigh          5,067,580      87.17%      746,006       12.83%
----------------------------------------------------------------------------
Mr. Chris A. Rallis       5,067,580      87.17%      746,006       12.83%
----------------------------------------------------------------------------
Mr. Rostislav Raykov      5,067,242      87.16%      746,344       12.84%
----------------------------------------------------------------------------
Mr. Steven D. Skolsky     5,067,572      87.17%      746,014       12.83%
----------------------------------------------------------------------------

Contacts:
Fennec Pharmaceuticals Inc.
Rosty Raykov
Chief Executive Officer
(919) 636-5144

Source: Fennec Pharmaceuticals Inc.

You May Also Be Interested In

• Across 26 US metros, majority of people say they have experienced housing discrimination
• Shift5 Introduces GPS Integrity Module to Combat GPS Spoofing Risks
• Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024